Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

INAB Company Profile and Key Details

NASDAQ : INAB

IN8bio, Inc.

$0.16
0.004+2.51%
At Close 4:00 PM
55.85
B-ESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

INAB Stock Price Chart

Stock Price Today

IN8bio, Inc. (INAB) stock surged +2.51%, trading at $0.16 on NASDAQ, up from the previous close of $0.16. The stock opened at $0.16, fluctuating between $0.16 and $0.17 in the recent session.

Stock Snapshot

0.1592
Prev. Close
0.16
Open
13.26M
Market Cap
81.26M
Number of Shares
0.1551
Day Low
0.1664
Day High
-0.29
P/E Ratio
71.05%
Free Float in %
-0.57
EPS (TTM)
0.7
Book Value
-0.67
Cash Flow per Share
223.46K
Volume

Relevant Articles

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 15, 20250.160.170.160.16224.63K
Apr 14, 20250.150.160.150.16664.8K
Apr 11, 20250.150.150.150.15594.71K
Apr 10, 20250.150.160.140.15342.41K
Apr 09, 20250.150.150.130.151.18M
Apr 08, 20250.150.160.150.15506.83K
Apr 07, 20250.160.160.140.15646.88K
Apr 04, 20250.160.160.140.151.41M
Apr 03, 20250.180.180.160.161M
Apr 02, 20250.170.180.160.17673.19K
Apr 01, 20250.170.180.170.17643.74K
Mar 31, 20250.190.200.160.171.88M
Mar 28, 20250.210.210.190.20713.35K
Mar 27, 20250.200.210.200.21507.14K
Mar 26, 20250.220.220.190.212.01M
Mar 25, 20250.230.230.210.22839.51K
Mar 24, 20250.240.240.230.23626.94K
Mar 21, 20250.230.240.220.23650.5K
Mar 20, 20250.240.250.230.23552.39K
Mar 19, 20250.230.250.230.24673.2K

Contact Details

New York, NY 10118

United States

Website: https://in8bio.comContact: 646 600 6438

About Company

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Company Information

Employees18
Beta0.23
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current IN8bio, Inc. (INAB) stock price?
IN8bio, Inc. (NASDAQ: INAB) stock price is $0.16 in the last trading session. During the trading session, INAB stock reached the peak price of $0.17 while $0.16 was the lowest point it dropped to. The percentage change in INAB stock occurred in the recent session was 2.51% while the dollar amount for the price change in INAB stock was $0.00.
INAB's industry and sector of operation?
The NASDAQ listed INAB is part of Biotechnology industry that operates in the broader Healthcare sector. IN8bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of INAB?
Mr. Patrick McCall CPA
Chief Financial Officer & Sec.
Mr. William Ho
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Kenneth R. LaMontagne Ph.D.
Senior Vice President of Bus. Devel.
Mr. Tai-Wei Ho
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Kate Rochlin Ph.D.
Chief Operating Officer
Dr. Trishna Goswami M.D.
Chief Medical Officer
Dr. Lawrence S. Lamb Ph.D.
Executive Vice President, Co-Founder & Chief Scientific Officer
How INAB did perform over past 52-week?
INAB's closing price is 22.71% higher than its 52-week low of $0.13 where as its distance from 52-week high of $1.74 is -90.62%.
How many employees does INAB have?
Number of INAB employees currently stands at 18.
Link for INAB official website?
Official Website of INAB is: https://in8bio.com
How do I contact INAB?
INAB could be contacted at phone 646 600 6438 and can also be accessed through its website. INAB operates from 350 5th Avenue, New York, NY 10118, United States.
How many shares of INAB are traded daily?
INAB stock volume for the day was 223.46K shares. The average number of INAB shares traded daily for last 3 months was 5.39M.
What is the market cap of INAB currently?
The market value of INAB currently stands at $13.26M with its latest stock price at $0.16 and 81.26M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Categories

InvestingCrypto NewsMarket NewsBusinessUS Stocks

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades and Downgrades52 Week Highs LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph